Get started
Author

Jūlija Zepa

Observed names: J Zepa, J. Zepa, Julija ZEPA, Julija Zepa, Zepa Julija, Zepa, Julija, Zepa, Jūlija
ORCID: 0000-0003-3848-797X
Observed ORCID: 0000-0003-3848-797X
OpenAlex ID: A5010684173
Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis: Results from the COVID-19 Global Rheumatology Alliance physician registry
2021 · Jeffrey A Sparks, Zachary S Wallace, et al. · Annals of the Rheumatic Diseases · 238
PDF
Association Between Tumor Necrosis Factor Inhibitors and the Risk of Hospitalization or Death Among Patients With Immune-Mediated Inflammatory Disease and COVID-19
2021 · Zara Izadi, Erica J. Brenner, et al. · JAMA Network Open · 116
PDF
Outcomes of COVID-19 in patients with primary systemic vasculitis or polymyalgia rheumatica from the COVID-19 Global Rheumatology Alliance physician registry: a retrospective cohort study
2021 · Sebastian E Sattui, Richard Conway, et al. · The Lancet Rheumatology · 51
PDF
SARS-CoV-2 breakthrough infections among vaccinated individuals with rheumatic disease: results from the COVID-19 Global Rheumatology Alliance provider registry
2022 · Jean Liew, Milena Gianfrancesco, et al. · RMD Open · 49
PDF
Differences and similarities in rheumatology specialty training programmes across European countries
2015 · Francisca Sivera, Sofia Ramiro, et al. · Annals of the Rheumatic Diseases · 22
Environmental and societal factors associated with COVID-19-related death in people with rheumatic disease: an observational study
2022 · Zara Izadi, Milena A Gianfrancesco, et al. · The Lancet Rheumatology · 19
PDF
SARS-CoV-2 vaccine safety in adolescents with inflammatory rheumatic and musculoskeletal diseases and adults with juvenile idiopathic arthritis: data from the EULAR COVAX physician-reported registry
2022 · Saskia Lawson-Tovey, Pedro M Machado, et al. · RMD Open · 12
PDF
Factors associated with disease flare following SARS-CoV-2 vaccination in people with inflammatory rheumatic and musculoskeletal diseases: results from the physician-reported EULAR Coronavirus Vaccine (COVAX) Registry
2024 · Bayram Farisogullari, Saskia Lawson-Tovey, et al. · Annals of the Rheumatic Diseases · 8
PDF
Obstetric outcomes in women with rheumatic disease and COVID-19 in the context of vaccination status
2022 · Sinead Maguire, Samar Al-Emadi, et al. · Lara D. Veeken · 6
PDF
Temporal trends in COVID-19 outcomes in people with rheumatic diseases in Ireland: data from the COVID-19 Global Rheumatology Alliance registry
2022 · Richard Conway, Elena Nikiphorou, et al. · Lara D. Veeken · 6
PDF
The Impact of Body Mass Index on Disease Progression in Ankylosing Spondylitis
2018 · Jūlija Zepa, Inita Buliņa, et al. · Proceedings of the Latvian Academy of Sciences Section B Natural Exact and Applied Sciences · 3
PDF
Prevalence and gender - specific analysis of a systemic sclerosis cohort in Latvia
2024 · Kristine Ivanova, Olga Ribakova, et al. · Orphanet Journal of Rare Diseases · 2
PDF
The Relationship of Candidate Gene Polymorphisms with Ankylosing Spondylitis and its Clinical Course. Summary of the Doctoral Thesis
2020 · Zepa, Jūlija · 2
PDF
Research Article CD40 rs4810485 T>G polymorphism and susceptibility to ankylosing spondylitis in the Latvian population
2018 · J. Zepa, L. Silamiķele, et al. · Genetics and Molecular Research · 2
PDF
POS1212 SARS-CoV-2 VACCINE SAFETY IN ADOLESCENTS WITH INFLAMMATORY RHEUMATIC AND MUSCULOSKELETAL DISEASES AND ADULTS WITH JUVENILE IDIOPATHIC ARTHRITIS
2022 · S. Lawson-Tovey, A. Strangfeld, et al. · Annals of the Rheumatic Diseases · 1
PDF
OA01 Safety of vaccination against SARS-CoV-2 in people with rheumatic and musculoskeletal diseases: results from the EULAR Coronavirus Vaccine (COVAX) physician-reported registry
2022 · Pedro M Machado, Saskia Lawson-Tovey, et al. · Lara D. Veeken · 1
Kandidātgēnu polimorfismu saistība ar ankilozējošo spondilītu un tā klīnisko gaitu. Promocijas darbs
2020 · Zepa, Jūlija · 1
PDF
Kandidātgēnu polimorfismu saistība ar ankilozējošo spondilītu un tā klīnisko gaitu. Promocijas darba kopsavilkums
2020 · Zepa, Jūlija · 1
PDF
ERN ReCONNET–SLICC–SLEuro consensus on the therapeutic management of rare systemic lupus erythematosus manifestations (part 2)
2026 · Laurent Arnaud, Odirlei A Monticielo, et al. · The Lancet Rheumatology
Outcomes of Vaccination Against SARS-CoV-2 in Patients with Rheumatic Diseases in Latvia
2024 · Inita Buliņa, Jūlija Zepa · Proceedings of the Latvian Academy of Sciences Section B Natural Exact and Applied Sciences
PDF
Outpatient Care Aspects of Rheumatic Patients in Latvia: Real Life Data in the Context of the First Month of the COVID-19 Pandemic
2023 · Jūlija Zepa, Vladimirs Lavrentjevs, et al. · Proceedings of the Latvian Academy of Sciences Section B Natural Exact and Applied Sciences
PDF
P61 SARS-CoV-2 vaccine safety in adolescents with inflammatory rheumatic and musculoskeletal diseases and adults with juvenile idiopathic arthritis: data from the EULAR COVAX physician-reported registry
2022 · Saskia Lawson-Tovey, Pedro Machado, et al. · Rheumatology Advances in Practice
Tolérance de la vaccination contre le SRAS-CoV-2 chez les patients atteints de maladies rhumatologiques inflammatoires/auto-immunes : résultats du registre EULAR-COVAX chez 5121 patients
2021 · X. Mariette, S. Lawson-Tovey, et al. · Revue du Rhumatisme
Characteristics of PCR confirmed COVID-19 cases in patients with autoimmune rheumatic diseases in Latvia
2021 · Inita Buliņa, A. Kadisa, et al. · RSU Research week 2021: Knowledge for Use in Practice
A5.14 The profile of axial spondyloarthritis patients according to fatigue level
2015 · J Zepa, I Bulina, et al. · Annals of the Rheumatic Diseases
Works count: 33
Citation count: 540
H-index: 8
I10-index: 7
Year
Topic
Type